PH26256A
(en)
*
|
1988-08-12 |
1992-04-01 |
Fujisawa Pharmaceutical Co |
Oxaspiro [2,5] octane derivative
|
EP0519428B1
(de)
*
|
1991-06-21 |
2000-09-20 |
Takeda Chemical Industries, Ltd. |
Zyklodextrin-Zusammensetzung enthaltend Fumagillol-Derivate
|
DE69311278T2
(de)
*
|
1992-12-16 |
1997-10-30 |
Takeda Chemical Industries Ltd |
Stabile pharmazeutische Zubereitung mit Fumagillolderivaten
|
US5710148A
(en)
*
|
1995-03-06 |
1998-01-20 |
Senju Pharmaceuticals Co., Ltd. |
Corneal opacification inhibitory composition
|
FR2733498B1
(fr)
*
|
1995-04-27 |
1997-05-30 |
Adir |
Nouveaux composes cyclohexaniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
CA2210600A1
(en)
*
|
1996-07-17 |
1998-01-17 |
Takashi Houkan |
Inhibitor of tumor metastasis or recurrence
|
WO1998056372A1
(en)
|
1997-06-09 |
1998-12-17 |
Massachusetts Institute Of Technology |
TYPE 2 METHIONINE AMINOPEPTIDASE (MetAP2) INHIBITORS AND USES THEROF
|
WO1999061432A1
(en)
*
|
1998-05-12 |
1999-12-02 |
Biochem Pharma Inc. |
Fumagillin analogs and their use as angiogenesis inhibitors
|
US6548477B1
(en)
|
2000-11-01 |
2003-04-15 |
Praecis Pharmaceuticals Inc. |
Therapeutic agents and methods of use thereof for the modulation of angiogenesis
|
US20070161570A1
(en)
*
|
2000-11-01 |
2007-07-12 |
Praecis Pharmaceuticals, Inc. |
Methionine aminopeptidase-2 inhibitors and methods of use thereof
|
PL366216A1
(en)
|
2000-11-01 |
2005-01-24 |
Praecis Pharmaceuticals Inc. |
Therapeutic agents and methods of use thereof for the modulation of angiogenesis
|
US7105482B2
(en)
|
2000-11-01 |
2006-09-12 |
Praecis Pharmaceuticals, Inc. |
Methionine aminopeptidase-2 inhibitors and methods of use thereof
|
US6919307B2
(en)
|
2000-11-01 |
2005-07-19 |
Praecis Pharmaceuticals, Inc. |
Therapeutic agents and methods of use thereof for the modulation of angiogenesis
|
KR100455900B1
(ko)
*
|
2001-09-27 |
2004-11-12 |
주식회사 아이디알 |
새로운 푸마질롤 유도체 및 그의 제조방법
|
WO2003027104A1
(en)
*
|
2001-09-27 |
2003-04-03 |
Idrtech Inc. |
Fumagillol derivatives and preparing method thereof
|
KR100483836B1
(ko)
*
|
2002-05-29 |
2005-04-20 |
주식회사 아이디알 |
푸마질롤 유도체 및 그의 제조방법
|
FR2832149B1
(fr)
*
|
2001-11-09 |
2006-01-06 |
Galderma Res & Dev |
Nouveaux inhibiteurs de l'angiogenese et leur utilisation pharmaceutique et cosmetique
|
US6803382B2
(en)
|
2001-11-09 |
2004-10-12 |
Galderma Research & Development, S.N.C. |
Angiogenesis inhibitors and pharmaceutical and cosmetic use thereof
|
CN102123586A
(zh)
*
|
2008-07-18 |
2011-07-13 |
法弗根股份有限公司 |
治疗超重或肥胖受试者的方法
|
WO2010065883A2
(en)
|
2008-12-04 |
2010-06-10 |
Zafgen Corporation |
Method of treating an overweight or obese subject
|
WO2010065877A2
(en)
|
2008-12-04 |
2010-06-10 |
Zafgen Corporation |
Methods of treating an overweight or obese subject
|
EP2486004B1
(de)
|
2009-10-09 |
2017-05-03 |
Zafgen, Inc. |
Sulfonverbindungen zur verwendung in der behandlung von adipositas
|
WO2011085198A1
(en)
|
2010-01-08 |
2011-07-14 |
Zafgen Corporation |
Metap-2 inhibitor for use in treating benign prostatic hypertrophy (bph)
|
BR112012016793A2
(pt)
|
2010-01-08 |
2018-07-31 |
Zafgen Corp |
compostos tipo fumagilol e métodos de fazer e usar os mesmos
|
WO2011088055A2
(en)
|
2010-01-12 |
2011-07-21 |
Zafgen Corporation |
Methods and compositions for treating cardiovascular disorders
|
WO2011127304A2
(en)
|
2010-04-07 |
2011-10-13 |
Zafgen Corporation |
Methods of treating an overweight subject
|
WO2012012642A1
(en)
|
2010-07-22 |
2012-01-26 |
Zafgen Corporation |
Tricyclic compounds and methds of making and using same
|
CA2817199C
(en)
|
2010-11-09 |
2019-01-15 |
Zafgen, Inc. |
Crystalline solids of a metap-2 inhibitor and methods of making and using same
|
US20140073691A1
(en)
|
2010-11-10 |
2014-03-13 |
Zafgen, Inc. |
Methods and composition for Treating Thyroid Hormone Related Disorders
|
WO2012074968A1
(en)
|
2010-11-29 |
2012-06-07 |
Zafgen Corporation |
Methods of reducing risk of hepatobiliary dysfunction during rapid weight loss with metap-2 inhibitors
|
MX2013005989A
(es)
|
2010-11-29 |
2013-08-21 |
Zafgen Inc |
Tratamiento de obesidad utilizando administracion no diaria de 6-o-(4-dimetilaminoetoxi)cinamoil fumagilol.
|
US9189078B2
(en)
|
2010-12-20 |
2015-11-17 |
Apple Inc. |
Enhancing keycap legend visibility with optical components
|
US9321740B2
(en)
|
2011-01-26 |
2016-04-26 |
Zafgen, Inc. |
Tetrazole compounds and methods of making and using same
|
BR112013023056A2
(pt)
|
2011-03-08 |
2018-10-09 |
Zafgen Inc |
derivados de oxaespiro [2,5] octano e análogos
|
EP2705035B1
(de)
|
2011-05-06 |
2016-12-14 |
Zafgen, Inc. |
Tricyclische pyrazolsulfonamidverbindungen sowie verfahren und herstellung zu ihrer herstellung
|
EP2705030B1
(de)
|
2011-05-06 |
2016-07-27 |
Zafgen, Inc. |
Teilweise gesättigten trizyklishen verbindungen, deren herstellung und verwendung
|
AU2012253759B2
(en)
|
2011-05-06 |
2016-01-21 |
Zafgen Inc. |
Tricyclic sulfonamide compounds and methods of making and using same
|
EP2763671A2
(de)
|
2011-10-03 |
2014-08-13 |
Zafgen, Inc. |
Verfahren zur behandlung von altersbedingten erkrankungen
|
AU2013209723B2
(en)
|
2012-01-18 |
2016-11-24 |
Zafgen, Inc. |
Tricyclic sulfonamide compounds and methods of making and using same
|
WO2013109735A1
(en)
|
2012-01-18 |
2013-07-25 |
Zafgen, Inc. |
Tricyclic sulfone compounds and methods of making and using same
|
KR20150016303A
(ko)
|
2012-05-07 |
2015-02-11 |
자프겐 인크. |
6-o-(4-디메틸아미노에톡시) 신나모일 푸마지롤의 옥살레이트 염의 다형체 염 및 이의 제조 및 사용 방법
|
CA2872876A1
(en)
|
2012-05-08 |
2013-11-14 |
Zafgen, Inc. |
Treating hypothalamic obesity with metap2 inhibitors
|
CN104364251B
(zh)
|
2012-05-09 |
2017-02-22 |
扎夫根股份有限公司 |
烟曲霉醇型化合物及其制备和使用方法
|
CN104870433A
(zh)
|
2012-11-05 |
2015-08-26 |
扎夫根股份有限公司 |
三环化合物及其制备方法和用途
|
CN104918928A
(zh)
|
2012-11-05 |
2015-09-16 |
扎夫根股份有限公司 |
三环化合物及其制备方法和用途
|
MX2015005734A
(es)
|
2012-11-05 |
2016-02-10 |
Zafgen Inc |
Metodos de tratamiento de enfermedades hepaticas.
|
MX362391B
(es)
|
2013-03-14 |
2019-01-15 |
Zafgen Inc |
Métodos de tratamiento de enfermedad renal y otros trastornos.
|
AR105671A1
(es)
|
2015-08-11 |
2017-10-25 |
Zafgen Inc |
Compuestos heterocíclicos de fumagillol y sus métodos de elaboración y uso
|
CN106432255A
(zh)
|
2015-08-11 |
2017-02-22 |
扎夫根公司 |
烟曲霉素醇螺环化合物和制备和使用其的方法
|
WO2023156996A1
(en)
|
2022-02-16 |
2023-08-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Metap2 inhibitors and uses thereof
|